Next Article in Journal
Role of Hepatic Progenitor Cells in Nonalcoholic Fatty Liver Disease Development: Cellular Cross-Talks and Molecular Networks
Next Article in Special Issue
HuR-Regulated mRNAs Associated with Nuclear hnRNP A1-RNP Complexes
Previous Article in Journal
Marine Polysaccharide Networks and Diatoms at the Nanometric Scale
Previous Article in Special Issue
Posttranscriptional Regulation of Insulin Family Ligands and Receptors
Open AccessReview

Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications

by 1,2, 1,2 and 1,2,*
1
Institute of Clinical Medicine, National Cheng Kung University, Tainan 704, Taiwan
2
Institute of Basic Medical Science, National Cheng Kung University, Tainan 704, Taiwan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2013, 14(10), 20079-20111; https://doi.org/10.3390/ijms141020079
Received: 5 July 2013 / Revised: 13 September 2013 / Accepted: 18 September 2013 / Published: 9 October 2013
(This article belongs to the Special Issue Post-Transcriptional Gene Regulation by Ribonucleoprotein Complexes)
Frontotemperal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) are two common neurodegenerative diseases. TDP-43 is considered to be a major disease protein in FTLD/ALS, but it’s exact role in the pathogenesis and the effective treatments remains unknown. To address this question and to determine a potential treatment for FTLD/ALS, the disease animal models of TDP-43 proteinopathy have been established. TDP-43 proteinopathy is the histologic feature of FTLD/ALS and is associated with disease progression. Studies on the disease animal models with TDP-43 proteinopathy and their pre-clinical applications are reviewed and summarized. Through these disease animal models, parts of TDP-43 functions in physiological and pathological conditions will be better understood and possible treatments for FTLD/ALS with TDP-43 proteinopathy may be identified for possible clinical applications in the future. View Full-Text
Keywords: amyotrophic lateral sclerosis; disease models; frontotemperal lobar degeneration; proteinopathy; TDP-43; therapy amyotrophic lateral sclerosis; disease models; frontotemperal lobar degeneration; proteinopathy; TDP-43; therapy
Show Figures

MDPI and ACS Style

Liu, Y.-C.; Chiang, P.-M.; Tsai, K.-J. Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications. Int. J. Mol. Sci. 2013, 14, 20079-20111. https://doi.org/10.3390/ijms141020079

AMA Style

Liu Y-C, Chiang P-M, Tsai K-J. Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications. International Journal of Molecular Sciences. 2013; 14(10):20079-20111. https://doi.org/10.3390/ijms141020079

Chicago/Turabian Style

Liu, Yu-Chih; Chiang, Po-Min; Tsai, Kuen-Jer. 2013. "Disease Animal Models of TDP-43 Proteinopathy and Their Pre-Clinical Applications" Int. J. Mol. Sci. 14, no. 10: 20079-20111. https://doi.org/10.3390/ijms141020079

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop